Attacks are ramping up on pharmaceutical companies for the cost of drugs, and notably when Hillary Clinton announced on the campaign trail her plan to impose price controls, the biotech sector immediately reacted with a market dip. Dr. Merrill Matthews tells the national Lars Larson Show the many reasons explaining the high cost of some prescription drugs, what solutions would lower their cost, and warns that regulations or price controls would only make them more expensive or ensure they never reach the market.
2015 11 05 Lars Larson Matthews High Cost of Prescription Drugs Rx